Clinical Pharmacokinetics of Mefloquine
暂无分享,去创建一个
[1] J. Karbwang,et al. Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers. , 1991, The Southeast Asian journal of tropical medicine and public health.
[2] N. White,et al. Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment. , 1990, The Journal of infectious diseases.
[3] C. C. Campbell,et al. Neurologic reactions after a therapeutic dose of mefloquine. , 1989, The New England journal of medicine.
[4] J. Bauchet,et al. Divided-dose kinetics of mefloquine in man. , 1989, British journal of clinical pharmacology.
[5] W. Wernsdorfer,et al. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. , 1989, British journal of clinical pharmacology.
[6] J. Karbwang,et al. Determination of mefloquine in biological fluids using high performance liquid chromatography. , 1989, The Southeast Asian journal of tropical medicine and public health.
[7] N. White,et al. Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. , 1987, British journal of clinical pharmacology.
[8] M. Molyneux,et al. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. , 1987, British journal of clinical pharmacology.
[9] N. White. COMBINATION TREATMENT FOR FALCIPARUM PROPHYLAXIS , 1987, The Lancet.
[10] O. V. Stetten,et al. High-performance liquid chromatographic analysis of mefloquine and its main metabolite by direct plasma injection with pre-column enrichment and column , 1986 .
[11] A. Breckenridge,et al. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. , 1985, British journal of clinical pharmacology.
[12] N. White,et al. Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. , 1985, The American journal of tropical medicine and hygiene.
[13] K. Silamut,et al. Binding of quinine to plasma proteins in falciparum malaria. , 1985, The American journal of tropical medicine and hygiene.
[14] N. White. Clinical Pharmacokinetics of Antimalarial Drugs , 1985, Clinical pharmacokinetics.
[15] T. Harinasuta,et al. TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA , 1985, The Lancet.
[16] R. Nagel,et al. On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug. , 1984, Biochimica et biophysica acta.
[17] Guoqiao Li,et al. ANTIMALARIAL ACTIVITY OF MEFLOQUINE AND QINGHAOSU , 1982, The Lancet.
[18] D. E. Schwartz,et al. Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring. , 1981, Biomedical mass spectrometry.
[19] J.D.R. Thomas. Recent developments in chromatography and electrophoresis , 1981 .
[20] D. E. Schwartz,et al. Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man. , 1980, Acta tropica.
[21] K. Barry,et al. Kinetics of a new antimalarial, mefloquine , 1979, Clinical pharmacology and therapeutics.
[22] J. Haslam,et al. GLC determination of whole blood antimalarial concentrations. , 1979, Journal of pharmaceutical sciences.
[23] C. D. Fitch,et al. Chloroquine Resistance in Malaria: Accessibility of Drug Receptors to Mefloquine , 1979, Antimicrobial Agents and Chemotherapy.
[24] N. Molek,et al. The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[25] J. M. Grindel,et al. Quantitation of the antimalarial agent, mefloquine, in blood, plasma, and urine using high-pressure liquid chromatography. , 1977, Journal of pharmaceutical sciences.
[26] P. Dayton,et al. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[27] N. White,et al. Absorption kinetics of mefloquine in pregnant patients with chloroquine-resistant falciparum malaria , 1990 .
[28] F. Churchill,et al. Determination of mefloquine by electron-capture gas chromatography after phosgene derivatization in biological samples and in capillary blood collected on filter paper. , 1988, Journal of chromatography.
[29] A. Breckenridge,et al. Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women. , 1988, Bulletin of the World Health Organization.
[30] U. Hellgren,et al. High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. , 1988, Journal of chromatography.
[31] P. Heizmann,et al. Single-dose kinetics of mefloquine in Brazilian male subjects. , 1987, Bulletin of the World Health Organization.
[32] W. Wernsdorfer,et al. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. , 1987, Bulletin of the World Health Organization.
[33] J. Karbwang. Clinical pharmacology of mefloquine. , 1987 .
[34] W. Wernsdorfer,et al. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. , 1987, Bulletin of the World Health Organization.
[35] U. Dubach,et al. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. , 1987, Chemotherapy.
[36] D. E. Schwartz,et al. Urinary excretion of mefloquine and some of its metabolites in African volunteers at steady state. , 1987, Chemotherapy.
[37] R. Lambe,et al. Gas chromatographic determination of mefloquine in human and dog plasma using electron-capture detection. , 1985, Journal of chromatography.
[38] U. Sheth,et al. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. , 1985, Bulletin of the World Health Organization.
[39] P. Heizmann,et al. Determination of the antimalarial mefloquine in human plasma by gas chromatography with electron-capture detection. , 1984, Journal of Chromatography A.
[40] J. M. Kofi Ekue,et al. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. , 1983, Bulletin of the World Health Organization.
[41] J. M. Souza. A phase II clinical trial of mefloquine in Brazilian male subjects. , 1983 .
[42] D. E. Schwartz,et al. Multiple-dose kinetic study of mefloquine in healthy male volunteers. , 1983, Chemotherapy.
[43] I. Kapetanovic,et al. Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography. , 1983, Journal of chromatography.
[44] D. Hartmann,et al. Single Dose Kinetics of Mefloquine in Man , 1982 .
[45] R. Lasserre,et al. Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. , 1982, Bulletin of the World Health Organization.
[46] E. Griesser,et al. [Metabolism of Ro 21-5998 (mefloquine) in the rat (author's transl)]. , 1980, Arzneimittel-Forschung.
[47] A. Frigerio,et al. Quantitative determination of the antimalarial drug mefloquine and of its main metabolite in plasma by direct densitometric measurement on thin-layer chromatographic plates. , 1980 .
[48] P. Phintuyothin,et al. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. , 1979, Bulletin of the World Health Organization.